May 22, 2013

Irish drug maker Elan is paying about $380 million to buy two drug makers, the company said.

May 21, 2013

Spending on specialty drugs is likely to increase by 67% over the next couple of years, according to a new study by pharmacy benefit manager Express Scripts.

May 20, 2013

The National Association of Specialty Pharmacy has appointed the leader of a cancer-focused specialty pharmacy to its board of directors.

May 17, 2013

A Food and Drug Administration panel will consider whether to recommend approval for an experimental painkiller in July, the drug's developer said Friday.

May 17, 2013

Hospira has reappointed its chief scientific officer after he briefly left the country earlier this year, the generic drug maker said.

May 17, 2013

More than two-thirds of patients with hepatitis C achieved sustained virologic response or cure after completing newer “triple therapy” treatment, according to a Walgreens Specialty Pharmacy study released Friday.

May 16, 2013

The National Association of Specialty Pharmacy has launched an online resource with clinical and business-related content in more than 20 therapeutic categories, the group said Thursday.

May 15, 2013

A federal drug track-and-trace bill has made it out of a congressional committee.

May 15, 2013

The Food and Drug Administration has approved a drug for a type of lung cancer.

May 15, 2013

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating ulcerative colitis, the agency said Wednesday.

May 15, 2013

A new treatment for late-stage prostate cancer has received approval from the Food and Drug Administration.

May 14, 2013

Diplomat Specialty Pharmacy is among the sponsors of a fundraising effort to expand an adult-fitness program run by a Flint, Mich.-based nonprofit.

May 14, 2013

Teva Health Systems has launched a generic injectable drug for small-cell lung cancer, the company said.

May 10, 2013

A biotech company and a non-profit organization are looking into new ways to treat patients with the devastating degenerative disorder commonly known as Lou Gehrig's disease.

May 10, 2013

The Food and Drug Administration has approved a biotech drug made by Novartis for treating a form of arthritis that affects children, the Swiss drug maker said Friday.

May 10, 2013

The Specialty Pharmacy Certification Board will begin certifying specialty pharmacists who pass a comprehensive exam in October. The exam is designed to cover the entire specialty pharmacy process, including intake, clinical management, fulfillment and outcomes.

The National Association of Specialty Pharmacy, which oversees the SPCB, is bringing to bear some real advocacy and structure to the highly fragmented specialty pharmacy marketplace. The DSN Group, including its specialty pharmacy publication of the same name Specialty Pharmacy, applauds these efforts.

May 10, 2013

The Specialty Pharmacy Certification Board has appointed Terri Smith Moore as the education director, the group said.

May 9, 2013

Cuts to Medicare payments due to the budget sequester have hit reimbursements for cancer drugs, according to a nonprofit group.

May 9, 2013

The Drug Enforcement Administration collected more than 371 tons of unused medications last month as part of its sixth annual drug take-back program, the agency said.

May 9, 2013

Declining use overall of healthcare services drove down spending on medicines in the United States by 3.5% per capita last year, according to a new study.

May 9, 2013

One of the difficulties that federal regulators ran into during the nationwide scandal surrounding the New England Compounding Center — the Massachusetts-based pharmacy blamed for a nationwide fungal meningitis epidemic that has sickened hundreds and killed dozens — was the issue of when such pharmacies cross the line from compounding to manufacturing.

May 7, 2013

Amid rapid growth over the last few years, Amber Pharmacy is more than doubling the size of its headquarters.

May 7, 2013

The outline of an exam that will be used to certify pharmacists working in the specialty channel has received approval from the Specialty Pharmacy Certification Board, the group said.

May 7, 2013

The global market for biosimilars will be worth nearly $2.5 billion this year, according to a new study.